Inflammation Research

, 58:345

First online:

Killer B lymphocytes: the evidence and the potential

  • Steven K. LundyAffiliated withDivision of Rheumatology, Department of Internal Medicine, University of Michigan Medical School Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Immune regulation plays a critical role in controlling potentially dangerous inflammation and maintaining health. The Fas ligand/Fas receptor axis has been studied extensively as a mechanism of killing T cells and other cells during infections, autoimmunity, and cancer. FasL expression has been primarily attributed to activated T cells and NK cells. Evidence has emerged that B lymphocytes can express FasL and other death-inducing ligands, and can mediate cell death under many circumstances. Among B cell subsets, the expression of both Fas ligand and IL-10 is highest on the CD5+ B cell population, suggesting that CD5+ B cells may have a specialized regulatory function. The relevance of killer B cells to normal immune regulation, disease pathogenesis, and inflammation is discussed.


B lymphocytes Immune regulation Fas ligand Th cell apoptosis Cell-based therapy